Sammanfattning
Many malignant tumours have increased TSPO expression, which has been related to a poor prognosis. TSPO-PET tracers have not comprehensively been evaluated in peripherally located tumours. This study aimed to evaluate whether N,N-diethyl-2-(2-(4-([18F]fluoro)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide ([18F]F-DPA) can reflect radiotherapy (RT)-induced changes in TSPO activity in head and neck squamous cell carcinoma (HNSCC).
| Originalspråk | Engelska |
|---|---|
| Sidor (från-till) | 1312-1326 |
| Antal sidor | 15 |
| Tidskrift | European Journal of Nuclear Medicine and Molecular Imaging |
| Volym | 48 |
| Nummer | 5 |
| DOI | |
| Status | Publicerad - 19 dec. 2020 |
| MoE-publikationstyp | A1 Tidskriftsartikel-refererad |
Fingeravtryck
Fördjupa i forskningsämnen för ”Evaluation of [ 18 F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy”. Tillsammans bildar de ett unikt fingeravtryck.Citera det här
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver